Sign in

    Sean Wirtjes

    Chief Financial Officer at Rapid Micro Biosystems Inc
    Since September 2018
    Age
    54 years
    Education
    Earned a B.S. in Accounting from the Carroll School of Management at Boston College.
    Tenure
    Joined Rapid Micro Biosystems, Inc. in September 2018 as Chief Financial Officer.

    Also at Rapid Micro Biosystems Inc

    About

    Sean Wirtjes is the Chief Financial Officer at Rapid Micro Biosystems, Inc., having assumed the role in September 2018. His current responsibilities include overseeing financial management and maintaining compliance with regulatory requirements.

    He earned a B.S. in Accounting from the Carroll School of Management at Boston College, which laid the foundation for his successful career in finance. Prior to joining Rapid Micro Biosystems, he gained valuable experience through other leadership roles, including a significant position at Boston Scientific Corporation.

    At 54 years old as of April 2024, his professional journey reflects a strong commitment to financial leadership and strategic oversight. His tenure at Rapid Micro Biosystems underscores his expertise in managing complex financial operations and ensuring organizational compliance.

    Past Roles

    OrganizationRoleDate RangeDetails
    Boston Scientific Corporation Vice President, Finance and Controller, Asia Pacific, Middle East, and Africa Aug 2012 - Jul 2016 Led all aspects of financial management for the region

    Fixed Compensation

    Data from  FY 2023
    Component NameAmountPayment ScheduleAdditional Details
    Base Salary$432,640 Annual4% increase from 2022 base salary
    401(k) Matching Contributions$13,966 As per plan annual contributionsPart of the company’s Savings and Investment Plan
    Insurance Premiums$14,607 AnnualCovers medical and life insurance
    Stock Awards$97,464 Granted during 2023RSUs granted with grant date fair value calculated per FASB ASC Topic 718
    Option Awards$125,118 Granted during 2023Options granted with full grant-date fair value per FASB ASC Topic 718
    Retention Bonus$62,400 Cash payment on/within 10 days after September 1, 2023 (or within 30 days upon qualifying termination)Contingent upon continued employment or qualifying termination; not performance-based

    Performance Compensation

    Data from  FY 2023

    Non-Equity Incentive Plan Compensation ($177,123) for FY 2023

    This cash bonus is determined by the achievement of both corporate and individual performance goals. Below is the detailed breakdown:

    MetricTarget/ThresholdWeight (%)Actual Achievement (%)Payout (%)Additional Details
    Commercial Execution & Revenue GrowthAs defined per plan50 76 29 Evaluated for FY 2023
    New Product Development100% target20 100 20 Achieved target exactly
    Customer Experience100% target10 127 13 Overachievement noted
    Gross Margin ImprovementN/A10 0 0 Target not met
    Employee Engagement, Recruitment & Development100% target10 200 20 Overachievement noted
    Total Corporate PerformanceComposite75*81 (aggregate) N/AWeighted aggregated performance
    Individual Performance GoalsN/A25 84 N/AEvaluated separately for FY 2023
    Target Bonus50% of Base SalaryN/AN/AN/AFinal bonus amount determined as $177,123

    *Corporate performance represents 75% of the overall performance evaluation. The bonus is cash-based, with no vesting schedule, grant date, or stock price since it is not share-based.